Search Results - "BEHRENS, Catherine"

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test by Wright, Thomas C, Stoler, Mark H, Behrens, Catherine M, Sharma, Abha, Zhang, Guili, Wright, Teresa L

“…Abstract Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer in women ≥ 25 years. This reports the 3-year end-of-study…”
Get full text

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study by Castle, Philip E, Dr, Stoler, Mark H, Prof, Wright, Thomas C, Prof, Sharma, Abha, PhD, Wright, Teresa L, MD, Behrens, Catherine M, MD

“…Summary Background The ATHENA study was designed to assess the performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping…”
Get full text

Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study by Cox, J. Thomas, MD, Castle, Phillip E., PhD, MPH, Behrens, Catherine M., MD, PhD, Sharma, Abha, PhD, Wright, Thomas C., MD, Cuzick, Jack, PhD

“…Objective The objective of the study was to compare 9 cervical cancer screening strategies to the current screening standard (cytology with human…”
Get full text

The ATHENA human papillomavirus study: design, methods, and baseline results by Wright, Thomas C., MD, Stoler, Mark H., MD, Behrens, Catherine M., MD, PhD, Apple, Raymond, PhD, Derion, Toniann, PhD, Wright, Teresa L., MD

“…Objective The objective of the study was to describe baseline data from Addressing the Need for Advanced HPV Diagnostics, a prospective, multicenter US…”
Get full text

Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial by Wright, Thomas C, Behrens, Catherine M, Ranger-Moore, James, Rehm, Susanne, Sharma, Abha, Stoler, Mark H, Ridder, Ruediger

“…Abstract Objectives In addition to genotyping for HPV16/18, dual-immunostaining for p16/Ki-67 has shown promise as a triage of HPV-positive women. We assessed…”
Get full text

Relevance of Random Biopsy at the Transformation Zone When Colposcopy Is Negative by Huh, Warner K., Sideri, Mario, Stoler, Mark, Zhang, Guili, Feldman, Robert, Behrens, Catherine M.

“…OBJECTIVE:A post hoc analysis to determine the diagnostic yield of random biopsy in detecting high-grade cervical disease in women with negative colposcopy…”
Get full text

Interlaboratory variation in the performance of liquid‐based cytology: Insights from the ATHENA trial by Wright, Thomas C., Stoler, Mark H., Behrens, Catherine M., Sharma, Abha, Sharma, Keerti, Apple, Raymond

“…Although it is recognized that cervical cytology is highly subjective, and that there is considerable interlaboratory variation in how slides are evaluated,…”
Get full text

Evaluating HPV‐negative CIN2+ in the ATHENA trial by Petry, Karl Ulrich, Cox, J. Thomas, Johnson, Kristin, Quint, Wim, Ridder, Ruediger, Sideri, Mario, Wright, Thomas C., Behrens, Catherine M.

“…A post hoc analysis of the ATHENA study was performed to determine whether true HPV‐negative cervical lesions occur and whether they have clinical relevance…”
Get full text

Performance of the cobas HPV Test for the Triage of Atypical Squamous Cells of Undetermined Significance Cytology in Cervical Specimens Collected in SurePath by Tewari, Devansu, Novak-Weekley, Susan, Hong, Christina, Aslam, Shagufta, Behrens, Catherine M

“…Abstract Objectives Determine performance of the cobas human papillomavirus (HPV) test for triage of atypical squamous cells of undetermined significance…”
Get full text

Development and Characterization of the cobas Human Papillomavirus Test by Rao, Arundhati, Young, Stephen, Erlich, Henry, Boyle, Sean, Krevolin, Mark, Sun, Rita, Apple, Raymond, Behrens, Catherine

“…Erratum ( vol. 51 , p. 4288 ) Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious…”
Get full text

Knowledge of Patients’ Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study by Wright, Thomas C., Stoler, Mark H., Aslam, Shagufta, Behrens, Catherine M.

“…Objectives: With human papillomavirus (HPV) testing, patients’ HPV status may be known when reviewing cytology specimens. Methods: 41,955 women 25 years or…”
Get full text

Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative Fluid by Krevolin, Mark D, Hardy, David, Pane, Jim, Aslam, Shagufta, Behrens, Catherine M

“…The formation of chemical cross-links between nucleic acids and proteins in formalin-containing media presents challenges for human papillomavirus (HPV)…”
Get full text

The Interplay of Age Stratification and HPV Testing on the Predictive Value of ASC-US Cytology: Results From the ATHENA HPV Study by STOLER, Mark H, WRIGHT, Thomas C, SHARMA, Abha, GUILI ZHANG, APPLE, Raymond, WRIGHT, Teresa L, BEHRENS, Catherine M

“…We have previously shown that human papillomavirus (HPV) genotyping, using the cobas HPV Test (Roche Molecular Systems, Pleasanton, CA), can be used to…”
Get full text

Human papillomavirus testing for triage of women with low‐grade squamous intraepithelial lesions by Cuzick, Jack, Thomas Cox, J., Zhang, Guili, Einstein, Mark H., Stoler, Mark, Trupin, Suzanne, Behrens, Catherine M.

“…Low‐grade squamous intraepithelial lesion (LSIL) is a common cytologic finding in cervical screening, yet only about 10–20% have significant histologic…”
Get full text

Primary Cervical Cancer Screening With Human Papillomavirus: End of Study Results From the ATHENA Study Using HPV as the First-Line Screening Test by Wright, Thomas C, Stoler, Mark H, Behrens, Catherine M, Sharma, Abha, Zhang, Guili, Wright, Teresa L

“…ABSTRACTHuman papillomavirus (HPV) testing has been used in the United States as a follow-up test for women with a cytology finding of atypical squamous cells…”
Get full text

The low risk of precancer after a screening result of human papillomavirus‐negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management by Gage, Julia C., Katki, Hormuzd A., Schiffman, Mark, Castle, Philip E., Fetterman, Barbara, Poitras, Nancy E., Lorey, Thomas, Cheung, Li C., Behrens, Catherine, Sharma, Abha, Zhao, Fang‐Hui, Cuzick, Jack, Yang, Zi Hua, Kinney, Walter K.

“…BACKGROUND Different US practice guidelines have conflicting recommendations for when women should return after a screening result of human papillomavirus…”
Get full text

Comparison of cobas human papillomavirus test results from primary versus secondary vials of PreservCyt specimens and evaluation of potential cross‐contamination by Rao, Arundhati, Young, Stephen, Krevolin, Mark, Sun, Rita, Purner, Matthew B., Sharma, Abha, Behrens, Catherine M.

“…BACKGROUND: The preferred workflow for high‐risk human papillomavirus (hrHPV) testing in the majority of laboratories involves cytology processing of samples…”
Get full text

The Interplay of Age Stratification and HPV Testing on the Predictive Value of ASC-US Cytology by Stoler, Mark H., Wright, Thomas C., Sharma, Abha, Zhang, Guili, Apple, Raymond, Wright, Teresa L., Behrens, Catherine M.

“…We have previously shown that human papillomavirus (HPV) genotyping, using the cobas HPV Test (Roche Molecular Systems, Pleasanton, CA), can be used to…”
Get full text

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial by Monsonego, Joseph, Cox, J. Thomas, Behrens, Catherine, Sandri, Maria, Franco, Eduardo L, Yap, Poh-Sin, Huh, Warner

“…Abstract Objective We assessed the age-related prevalence of high risk human papillomavirus (HR-HPV) genotypes and the genotype-associated risk for high-grade…”
Get full text

Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management by Castle, Philip E, Aslam, Shagufta, Behrens, Catherine

“…Cervical cancer risks, estimated by using cervical intraepithelial neoplasia grade 3 (CIN3) or more severe diagnoses (≥CIN3) endpoints, have not been…”
Get full text